Kaiser accuses California ex-employee of embezzling $7 million

http://www.latimes.com/business/la-fi-kaiser-embezzling-20160711-snap-story.html?utm_campaign=KHN%3A+First+Edition&utm_source=hs_email&utm_medium=email&utm_content=31540667&_hsenc=p2ANqtz-9I1Lf0kh4VxReez7DQie-7-_DAWq4kcCNyN4g1i050v34c-SFnUAiO5l7SllcW7_0DnMjKGEIcPGM8fHZ8E47NeCvnaQ&_hsmi=31540667

Dollars

A subsidiary of healthcare giant Kaiser Permanente has filed a lawsuit in California accusing a former employee responsible for investigating insurance fraud claims of embezzling $7 million.

The suit by Kaiser Foundation Health Plan accuses Michael Albert Quinn of submitting invoices for investigative services that were not performed or were not justified over a 16-year span after he joined the company in 1998.

Quinn, 45, worked in Oakland and was responsible for hiring investigators to conduct surveillance on people who were suspected of filing fraudulent claims, the suit says. It says he was authorized to approve charges of as much as $50,000.

A ‘slow catastrophe’ unfolds as the golden age of antibiotics comes to an end

http://www.latimes.com/science/sciencenow/la-sci-antibiotic-resistance-20160711-snap-story.html

Rosslyn Maybank

In early April, experts at a military lab outside Washington intensified their search for evidence that a dangerous new biological threat had penetrated the nation’s borders.

They didn’t have to hunt long before they found it.

On May 18, a team working at the Walter Reed Army Institute of Research here had its first look at a sample of the bacterium Escherichia coli, taken from a 49-year-old woman in Pennsylvania. She had a urinary tract infection with a disconcerting knack for surviving the assaults of antibiotic medications. Her sample was one of six from across the country delivered to the lab of microbiologist Patrick McGann.

Within hours, a preliminary analysis deepened concern at the lab. Over the next several days, more sophisticated genetic sleuthing confirmed McGann’s worst fears.

There, in the bacterium’s DNA, was a gene dubbed mcr-1. Its presence made the pathogen impervious to the venerable antibiotic colistin.

Can the government encourage the development of new antibiotics?

http://www.latimes.com/science/sciencenow/la-sci-sn-antibiotic-resistance-government-incentives-20160711-snap-story.html?utm_campaign=KHN%3A+First+Edition&utm_source=hs_email&utm_medium=email&utm_content=31540667&_hsenc=p2ANqtz-8KSOwnDu9wgUrlDN8u_2HnowEpWjJZShjqIFvN-mLC_3gavkn6QZ5XuGYVoKPH71cmkDrEhbc1BXnicLRSAOV4ZkDaTQ&_hsmi=31540667

Antibiotics

It’s been nearly 30 years since scientists have found a new class of antibiotics. But U.S. lawmakers tried to give the drug industry a boost in 2012.

That year, they passed the Food and Drug Administration Safety and Innovation Act. It included provisions — collectively known as Generating Antibiotic Incentives Now, or GAIN — aimed at streamlining the government approval process for new antibiotics. It also boosted financial paybacks to drug companies that develop them.

Superbug gene detected in a second person in the U.S.

https://www.washingtonpost.com/news/to-your-health/wp/2016/07/11/superbug-gene-detected-in-a-second-person-in-the-u-s/?_hsenc=p2ANqtz-8uNmEmwwUG1vB6aWRtwXfQdBo_rxN0ZbP2Z7U_lywUgo6QUrJKB5yjM0Y_0ZZoKwGCKxfZRBKs-t8lfLoJoLE5NCnJmg&_hsmi=31540667&utm_campaign=KHN%3A%20First%20Edition&utm_content=31540667&utm_medium=email&utm_source=hs_email

Researchers have found bacteria resistant to the antibiotic of last resort in a sample from a second patient in the United States, according to a study published Monday. The patient had surgery at a New York hospital last year, researchers said.

The news comes after researchers reported in late May that a patient in Pennsylvania carried a strain of E. coli bacteria that was resistant to colistin, the antibiotic that doctors use to treat patients who have infections that don’t respond to other drugs.

In both cases, the bacteria carried a gene, known as mcr-1, that allows the organism to withstand colistin. The Pennsylvania case was the first time this colistin-resistance gene had shown up in the United States after its identification in China last fall. Health officials and infectious-disease experts around the world have sounded the alarm because the gene has since been found in more than two dozen countries, in animals as well as people.

Radiologists Take On Bigger Role in Diagnosing

http://www.wsj.com/articles/radiologists-take-on-bigger-role-in-diagnosing-1468261106?utm_campaign=KHN%3A+First+Edition&utm_source=hs_email&utm_medium=email&utm_content=31540667&_hsenc=p2ANqtz-_0Pi-yLJKkgRXeSz30YgGrRQJo-l6X7K8_V5U8he3tQDl1M1kRhpstr8Ok1FboF5hRM12Pdh6HySpemIkTlJVY7kWWig&_hsmi=31540667

Dr. Michael Recht, head of radiology at NYU Langone, has been working to more closely integrate his fellow radiologists with the hospital’s clinical teams. Radiologists shouldn’t simply interpret images but should also help with medical decision-making.

The doctors who interpret imaging scans have begun working more closely with physicians who make medical decisions for patients at NYU Langone Medical Center.

Congress Shouldn’t Pass The 21st Century Cures Act In A Summer Rush

http://healthaffairs.org/blog/2016/07/11/congress-shouldnt-pass-the-21st-century-cures-act-in-a-summer-rush/

Blog_Capitol2

On Saturday June 25, six former FDA commissioners from Democratic and Republican administrations suggested at the Aspen Ideas Festival that Congress make the agency independent of the Department of Health and Human Services — similar to the Securities Exchange Commission, for example. With regulatory purview over products that represent a quarter of the U.S. economy, the group said the FDA is harmed by an unstable federal budget process and persistent political meddling. The group said they would issue a white paper on their proposal for the next administration. That’s another reason why Congress should postpone consideration of these bills until 2017.

Trump: Plan to Revamp Veterans Care Will Save Lives

http://www.nytimes.com/aponline/2016/07/11/us/ap-us-campaign-2016-trump.html?utm_campaign=CHL%3A+Daily+Edition&utm_source=hs_email&utm_medium=email&utm_content=31499894&_hsenc=p2ANqtz-95gg60n08D23FQGKFpBLfAu1j1mtnpE3_NxIAGaHU92xjAY3G7ttRr2f2du6US6m5cRMSj5Q1wAS_NJdxm82TCUpQkXA&_hsmi=31499894

 

In Nod to Sanders, Clinton Offers New Health Care Proposals

http://www.nytimes.com/aponline/2016/07/09/us/ap-us-dem-2016-clinton-health-care.html?utm_campaign=CHL%3A+Daily+Edition&utm_source=hs_email&utm_medium=email&utm_content=31499894&_hsenc=p2ANqtz-_YVFuV6N-xd__Ij8NeuODTC1G45rv_nDpH-lD8mfWo9RVqCpIS4TlEHahl3hu9_slRYFpZJvUCv1oIF7xCOxVI5gIXnA&_hsmi=31499894&_r=0

Medicare3

Clinton’s campaign says the proposal is part of her plan to provide universal health care coverage in the United States. The presumptive Democratic presidential nominee also is reaffirming her support for a public-option insurance plan and for expanding Medicare by letting people age 55 year and older opt in.